Osaka University starts trial of iPS cell-derived cardiomyocyte sheets

Researchers at Osaka University (Osaka, Japan) started a clinical trial evaluating an induced pluripotent stem (iPS) cell-based therapy to treat severe ischemic cardiomyopathy. The trial will assess s...